Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EYSM IS A STRONG BUY!
http://www.barchart.com/quotes/stocks/EYSM
Also look at the directional index; DI+ is sbove DI- which means that an uptrend is confirmed.
GO EYSM!
EYSM IS A STRONG BUY!
http://www.barchart.com/quotes/stocks/EYSM
Also look at the directional index; DI+ is sbove DI- which means that an uptrend is confirmed.
GO EYSM!
EYSM IS A STRONG BUY!
http://www.barchart.com/quotes/stocks/EYSM
Also look at the directional index; DI+ is sbove DI- which means that an uptrend is confirmed.
GO EYSM!
EYSM STILL A STRONG BUY!!!
http://www.barchart.com/quotes/stocks/EYSM
Look at the barchart I sent in my previous posts. EYSM is doing great!!
GO EYSM!
EYSM IS DOING WELL!!!
LOOK AT THE BARCHART!
ONCE WE BREAK 0,004 THIS BABY WILL RUN!!!
http://www.barchart.com/opinions/stocks/EYSM
HTDS
SHENZEN, CHINA--(Marketwire - 03/03/11) - Hard to Treat Diseases, Inc. (PINK SHEETS:HTDS - News) (www.htdsmedical.com) announced today that its China-based Shenzhen Mellow Hope subsidiary is planning a seminar for Indian medical experts.
The Indian experts are expected in China for the seminar and will visit Chinese medical experts in Beijing, Shanghai and Shenzhen. They will discuss plans to market 'Cognistar' (Cerebroprotein Hydrolysate for Injection) in India. Mellow Hope believes that this product will receive wide acceptance in the Indian market and has huge growth potential.
Mellow Hope finished the clinical trials of Cerebroprotein Hydrolysate for Injection in India. This biological product is a unique nutriment for the brain that helps the central nervous system in multiple ways, including: regulating and improving nerve cell metabolism; promoting synapse generation; inducing nerve cell differentiation; and protecting nerve cells against damages by ischemia and neurotoxins.
Mellow Hope looks forward to the visit from the Indian medical experts and plans to update investors as these developments progress.
HTDS! Volume reached nearly 400M shares on friday!
Breakout will happen soon IMO.
Registration certificate for Cognistar approved in India.
Once HTDS starts selling Cognistar this will add big $$$$$.
It is dirty cheap right now! Once we break 0,0003 and 0,0004 this can really run!
Last two quarters both positive, with net profit arround 350,000$ each quarter. Next Q will be good too IMO.
DO YOUR OWN DD IN BUYING ANY STOCK!
HTDS! Volume reached nearly 400M shares on friday!
Breakout will happen. It is dirty cheap right now!
Registration certificate approved in India. Once it starts selling Cognistar this will add big $$$$$$$$$$$.
IMO it is very undervalued right now!
Last two quarters both positive, net profit arround 350,000$ each quarter. Next Q will be also good IMO!
News should be out soon-> about merger and buying shares back.
DO YOUR OWN DD IN BUYING ANY STOCK!!
HTDS! Volume reached nearly 400M shares on friday.
Breakout will happen. IMO it can reach 0,0005 or 0,0006 or even higher very easily.
Last two quarters both positive with net profit arround 350,000$ each quarter. News about merger should be out soon. DIRTY CHEAP RIGHT NOW!
DO YOUR OWN DD IN BUYING ANY STOCK!!
This coming week this baby will go up.
News should be out soon.
GO EYSM!!!
HTDS! Volume reached nearly 400M shares on friday.
Look for breakout, it can easily reach 0,0005 or 0,0006 or even higher this coming week.
The last two quarters both positive, witn net profit arround 350,000$ each. News about merger and shares buyback should be out soon. Dirty cheap right now!
DO YOUR OWN DD IN BUYING ANY STOCK!!
You are right, IMO at the end of month we will all be smiling.
The price will go up, starting this coming week. Too much potential here, that is why bashers are here!
GO EYSM!!!
THEY CAN BUY AT 0,002 IN THEIR DREAMS, BUT NOT ON THE MARKET!
LMAO!!
GO EYSM!!!!! $$$$$$$$$$
EYSM WILL GO UP!
GO EYSM!! WE EXPECT NEWS!!
$$$$$$$
This coming week should be interesting IMO!!
If we get some good news-> pennyland soon.
GO EYSM!!!!
HTDS VOLUME SKYROCKETED!!!
REGISTRATION CERTIFICATE FOR COGNISTAR APPROVED IN INDIA!!
READ THE LAST PR!! THEY WILL START SELLING IT. HUGE POTENTIAL!!!
LAST TWO QUARTERS BOTH POSITIVE, NET PROFIT ARROUND 350,000$ EACH QUARTER.
DIRTY CHEAP RIGHT NOW!!
IT WILL START MOVING IMO!
DO YOUR OWN DD IN BUYING ANY STOCK.
HTDS VOLUME SKYROCKETING!
LAST QUARTERS BOTH POSITIVE, ARROUND 350,000$ EACH!!
DO YOUR OWN DD IN BUYING ANY STOCK!
HTDS VOLUME SKYROCKETING!
LOOK AT HTDS!
BOTH QUARTERS POSITIVE, NET INCOME ARROUND 350,000$ EACH!
DO YOUR OWN DD IN BUYING ANY STOCK!!
BUY HTDS, NEWS OUT!!
REGISTRATION CERTIFICATE FOR COGNISTAR APPROVED IN INDIA!!
LAST TWO QUARTERS BOTH POSITIVE, NET PROFIT ARROUND 350,000$ EACH QUARTER!!
DIRTY CHEAP RIGHT NOW!! JUST LOOK IT!
DO YOUR OWN DD IN BUYING ANY STOCK!!
HTDS!! TAKE A LOOK AT!!
HTDS-> LAST TWO QUARTERS BOTH POSITIVE, ARROUND 350,000$ EACH!!
REGISTRATION CERTIFICATE FOR COGNISTAR APPROVED IN INDIA!!
DIRTY CHEAP RIGHT NOW!! WAITING NEWS ABOUT MERGER!!
DO YOUR OWN DD IN BUYING ANY STOCK!!
HTDS NEWS!!
Hard to Treat Diseases, Inc. (PINK SHEETS: HTDS) (www.htdsmedical.com) announced today that its China-based Shenzhen Mellow Hope subsidiary is planning a seminar for Indian medical experts.
The Indian experts are expected in China for the seminar and will visit Chinese medical experts in Beijing, Shanghai and Shenzhen. They will discuss plans to market 'Cognistar' (Cerebroprotein Hydrolysate for Injection) in India. Mellow Hope believes that this product will receive wide acceptance in the Indian market and has huge growth potential.
Mellow Hope finished the clinical trials of Cerebroprotein Hydrolysate for Injection in India. This biological product is a unique nutriment for the brain that helps the central nervous system in multiple ways, including: regulating and improving nerve cell metabolism; promoting synapse generation; inducing nerve cell differentiation; and protecting nerve cells against damages by ischemia and neurotoxins.
Mellow Hope looks forward to the visit from the Indian medical experts and plans to update investors as these developments progress.
REGISTRATION CERTIFICATE APPROVED IN INDIA!!
LAST TWO QUARTERS BOTH POSITIVE WITH NET PROFIT ARROUND 350,000$ EACH.
DO YOUR OWN DD IN BUYING ANY STOCK!!
Good morning flyboy and the other boys!!
EYSM is really thin right now!
GO EYSM!! $$$$$$$$
HTDS NEWS!!
Hard to Treat Diseases, Inc. (PINK SHEETS: HTDS) (www.htdsmedical.com) announced today that its China-based Shenzhen Mellow Hope subsidiary is planning a seminar for Indian medical experts.
The Indian experts are expected in China for the seminar and will visit Chinese medical experts in Beijing, Shanghai and Shenzhen. They will discuss plans to market 'Cognistar' (Cerebroprotein Hydrolysate for Injection) in India. Mellow Hope believes that this product will receive wide acceptance in the Indian market and has huge growth potential.
Mellow Hope finished the clinical trials of Cerebroprotein Hydrolysate for Injection in India. This biological product is a unique nutriment for the brain that helps the central nervous system in multiple ways, including: regulating and improving nerve cell metabolism; promoting synapse generation; inducing nerve cell differentiation; and protecting nerve cells against damages by ischemia and neurotoxins.
Mellow Hope looks forward to the visit from the Indian medical experts and plans to update investors as these developments progress.
REGISTRATION CERTIFICATE FOR COGNISTAR APPROVED IN INDIA!!!
DIRTY CHEAP RIGHT NOW!
DO YOUR OWN DD IN BUYING ANY STOCK!
HTDS NEWS!
Hard to Treat Diseases, Inc. (PINK SHEETS: HTDS) (www.htdsmedical.com) announced today that its China-based Shenzhen Mellow Hope subsidiary is planning a seminar for Indian medical experts.
The Indian experts are expected in China for the seminar and will visit Chinese medical experts in Beijing, Shanghai and Shenzhen. They will discuss plans to market 'Cognistar' (Cerebroprotein Hydrolysate for Injection) in India. Mellow Hope believes that this product will receive wide acceptance in the Indian market and has huge growth potential.
Mellow Hope finished the clinical trials of Cerebroprotein Hydrolysate for Injection in India. This biological product is a unique nutriment for the brain that helps the central nervous system in multiple ways, including: regulating and improving nerve cell metabolism; promoting synapse generation; inducing nerve cell differentiation; and protecting nerve cells against damages by ischemia and neurotoxins.
Mellow Hope looks forward to the visit from the Indian medical experts and plans to update investors as these developments progress.
HTDS IS DIRTY CHEAP RIGHT NOW. REGISTRATION CERTIFICATE FOR COGNISTAR APPROVED IN INDIA. LAST TWO QUARTERS BOTH POSITIVE WITH NET PROFIT ARROUND 350,000$.
DO YOUR OWN DD IN BUYING ANY STOCK!!
HTDS NEWS OUT!
Hard to Treat Diseases, Inc. (PINK SHEETS: HTDS) (www.htdsmedical.com) announced today that its China-based Shenzhen Mellow Hope subsidiary is planning a seminar for Indian medical experts.
The Indian experts are expected in China for the seminar and will visit Chinese medical experts in Beijing, Shanghai and Shenzhen. They will discuss plans to market 'Cognistar' (Cerebroprotein Hydrolysate for Injection) in India. Mellow Hope believes that this product will receive wide acceptance in the Indian market and has huge growth potential.
Mellow Hope finished the clinical trials of Cerebroprotein Hydrolysate for Injection in India. This biological product is a unique nutriment for the brain that helps the central nervous system in multiple ways, including: regulating and improving nerve cell metabolism; promoting synapse generation; inducing nerve cell differentiation; and protecting nerve cells against damages by ischemia and neurotoxins.
Mellow Hope looks forward to the visit from the Indian medical experts and plans to update investors as these developments progress.
HTDS IS DIRTY CHEAP RIGHT NOW! THE REGISTRATION CERTIFICATE FOR COGNISTAR APPROVED IN INDIA!!
DO YOUR OWN DD IN BUYING ANY STOCK!
HTDS NEWS OUT!
Hard to Treat Diseases, Inc. (PINK SHEETS: HTDS) (www.htdsmedical.com) announced today that its China-based Shenzhen Mellow Hope subsidiary is planning a seminar for Indian medical experts.
The Indian experts are expected in China for the seminar and will visit Chinese medical experts in Beijing, Shanghai and Shenzhen. They will discuss plans to market 'Cognistar' (Cerebroprotein Hydrolysate for Injection) in India. Mellow Hope believes that this product will receive wide acceptance in the Indian market and has huge growth potential.
Mellow Hope finished the clinical trials of Cerebroprotein Hydrolysate for Injection in India. This biological product is a unique nutriment for the brain that helps the central nervous system in multiple ways, including: regulating and improving nerve cell metabolism; promoting synapse generation; inducing nerve cell differentiation; and protecting nerve cells against damages by ischemia and neurotoxins.
Mellow Hope looks forward to the visit from the Indian medical experts and plans to update investors as these developments progress.
THE LAST TWO QUARTERS BOTH POSITIVE. RIGHT NOW IT IS DIRTY CHEAP.
ONCE IT GETS MORE VOLUME IT WILL GO UP.
DO YOUR OWN DD IN BUYING ANY STOCK!
GOOD LUCK
HTDS NEWS OUT!!
Hard to Treat Diseases, Inc. (PINK SHEETS: HTDS) (www.htdsmedical.com) announced today that its China-based Shenzhen Mellow Hope subsidiary is planning a seminar for Indian medical experts.
The Indian experts are expected in China for the seminar and will visit Chinese medical experts in Beijing, Shanghai and Shenzhen. They will discuss plans to market 'Cognistar' (Cerebroprotein Hydrolysate for Injection) in India. Mellow Hope believes that this product will receive wide acceptance in the Indian market and has huge growth potential.
Mellow Hope finished the clinical trials of Cerebroprotein Hydrolysate for Injection in India. This biological product is a unique nutriment for the brain that helps the central nervous system in multiple ways, including: regulating and improving nerve cell metabolism; promoting synapse generation; inducing nerve cell differentiation; and protecting nerve cells against damages by ischemia and neurotoxins.
Mellow Hope looks forward to the visit from the Indian medical experts and plans to update investors as these developments progress.
HTDS NEWS OUT!!! HTDS is the biggest exporter of vaccines in China.
Last two quarters both positive. Once the news come out this will go up, it just needs volume. In the past it ran huge. The last two quarters both positive as I said.
DO YOUR OWN DD IN BUYING ANY STOCK!! THIS ONE IS DIRTY CHEAP RIGHT NOW! 0,0002 will soon be a dream.
DO YOUR OWN DD!!
Better every day, I have been loading from the range 0,0025 and on in few days. GREEN!! I like GREEN!!
GO EYSM!!$$$$$$$$$$$$$$
I loaded 8 mill today. My bag is full. Not selling before cents level. I believe in EYSM!!!
GO EYSM!!! $$$$$$$$$$$$
POWER HOUR!! DADDY NEEDS SHARES!!!!
GO EYSM!!! $$$$$$$$$$$$$
Lets go through 0,0037 like BULLDOZER!!!!!
GO EYSM!!! Power hour coming!!
0,004 or o,0042 today would be very nice!
HTDS!!!! It ran huge in the past. The last two quarters both positive. Merger news should be out soon.
Registration certificate for Cognistar approved in India.
Right now it is dirty cheap!
Do your own dd in investing in any type of stocks!
Lets go through 0,0035 like BULLDOZER!!!!!
GO EYSM!!!$$$$$$$$$$$
Once PR about A/S reduction or name change is out-> kaboom
Loading up cheapies.
GO EYSM!!!!!!!!!$$$$$$$$$$$